IPOs

CureVac grabs $213M in US IPO, adding to year's record pace
BioPharma Dive
Fri, 08/14/20 - 09:44 am
CureVac
IPOs
vaccines
CanSino reaps $748M windfall from Shanghai IPO — as it warns Covid-19 vaccine won't be a huge money maker
Endpoints
Thu, 08/13/20 - 09:54 am
CanSino
Shanghai
IPOs
vaccines
COVID-19
How the biotech capital markets are faring in the time of Covid-19
MedCity News
Fri, 08/7/20 - 10:50 am
biotech
capital
IPOs
funding
M&A
Kymera Therapeutics, fresh off a $2B Sanofi biobucks pact, guns for an IPO
Fierce Biotech
Mon, 08/3/20 - 10:19 am
Kymera Therapeutics
IPOs
Sanofi
protein degradation
AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients
Xconomy
Thu, 07/30/20 - 11:20 pm
AlloVir
IPOs
cell therapies
organ transplant
Inhibrx takes a second shot at an IPO — this time bumping the goal to $100M-plus
Endpoints
Wed, 07/29/20 - 11:52 pm
Inhibrx
IPOs
Why Some Biotech Companies Are Turning to SPACs
Motley Fool
Tue, 07/28/20 - 10:52 am
biotech
SPAC
special purpose acquisition company
IPOs
Therapeutics Acquisition
This week's wave of biotech IPO players bumps up offerings and targets bigger harvests of cash
Endpoints
Thu, 07/23/20 - 11:16 am
IPOs
biotech
Inozyme Pharma
Annexon
AlloVir
Nurix Therapeutics
Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
Pharmaforum
Mon, 07/20/20 - 11:51 pm
IPOs
Inozyme Pharma
rare bone diseases
China's CRO powerhouse Tigermed to seek $1B IPO in Hong Kong — report
Endpoints
Mon, 07/20/20 - 10:22 am
China
Hong Kong
Hangzhou Tigermed
CRO
biotech
IPOs
Three more biotechs tumble onto Wall Street today, raising $475M as the IPO party rocks on
Endpoints
Fri, 07/17/20 - 10:52 am
IPOs
ALX Oncology
Berkeley Lights
Pandion Therapeutics
NASDAQ
Relay Therapeutics prices IPO at $400M
MedCity News
Thu, 07/16/20 - 10:47 am
Relay Therapeutics
IPOs
drug discovery
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments
Xconomy
Mon, 07/13/20 - 11:33 pm
biotech
IPOs
Nkarta Therapeutics
Poseida Therapeutics
Inventiva
Another four biotechs scratch out the first number and ask for more as IPO boom continues
Endpoints
Fri, 07/10/20 - 11:00 am
IPOs
biotech
Relay Therapeutics
Nkarta Therapeutics
Poseida Therapeutics
Inventiva
Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts
Endpoints
Fri, 07/10/20 - 10:52 am
biotech
IPOs
HKEX
Hong Kong
Ocumension Therapeutics
Immunotech Biopharm
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
FDA lifts partial hold on ADC, clearing way for a 2021 readout and two potential near-term approvals
Endpoints
Mon, 07/6/20 - 11:01 am
ADC Therapeutics
IPOs
FDA
Cami
Hodgkin's lymphoma
Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Fierce Biotech
Tue, 06/30/20 - 10:35 am
Mereo BioPharma
IPOs
OncoMed
R&D
The biotech IPO boom is becoming ‘historic’ as four more throw their hats in
Endpoints
Mon, 06/29/20 - 10:34 am
IPOs
biotech
Berkeley Lights
ALX Oncology
Pandion Therapeutics
Kiromic Biopharma
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs
Xconomy
Thu, 06/25/20 - 10:45 am
Relay Therapeutics
IPOs
protein motion
cancer

Pages